MAFLD: Now is the time to capitalize on the momentum
- PMID: 33587953
- DOI: 10.1016/j.jhep.2021.02.002
MAFLD: Now is the time to capitalize on the momentum
Conflict of interest statement
Conflict of interest The authors declare no competing interests or any conflict of interest. Please refer to the accompanying ICMJE disclosure forms for further details.
Comment on
-
MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease.Gastroenterology. 2020 May;158(7):1999-2014.e1. doi: 10.1053/j.gastro.2019.11.312. Epub 2020 Feb 8. Gastroenterology. 2020. PMID: 32044314 Review.
-
A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement.J Hepatol. 2020 Jul;73(1):202-209. doi: 10.1016/j.jhep.2020.03.039. Epub 2020 Apr 8. J Hepatol. 2020. PMID: 32278004 Review.
-
The sub-Saharan Africa position statement on the redefinition of fatty liver disease: From NAFLD to MAFLD.J Hepatol. 2021 May;74(5):1256-1258. doi: 10.1016/j.jhep.2021.01.015. Epub 2021 Jan 20. J Hepatol. 2021. PMID: 33484771 No abstract available.
-
Hypertension in NAFLD: An uncontrolled burden.J Hepatol. 2021 May;74(5):1258-1260. doi: 10.1016/j.jhep.2021.01.019. Epub 2021 Jan 22. J Hepatol. 2021. PMID: 33485968 No abstract available.
-
Capturing patient experience: A qualitative study of change from NAFLD to MAFLD real-time feedback.J Hepatol. 2021 May;74(5):1261-1262. doi: 10.1016/j.jhep.2021.01.022. Epub 2021 Jan 23. J Hepatol. 2021. PMID: 33497764 No abstract available.
-
Change from NAFLD to MAFLD increases the awareness of fatty liver disease in primary care physicians and specialists.J Hepatol. 2021 May;74(5):1254-1256. doi: 10.1016/j.jhep.2020.12.035. Epub 2021 Feb 11. J Hepatol. 2021. PMID: 33582129 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
